What happened: IPC conclave on “Indian Pharmacopoeia (IP) 2026” and launch of reference standards
The Indian Pharmacopoeia Commission (IPC), under the Ministry of Health & Family Welfare, Government of India, organised a Scientific Conclave and Interactive Session on “Indian Pharmacopoeia (IP) 2026: Advancing Quality, Safety, and Innovation in Drugs, Food and Phytopharmaceuticals”. The event was held at the National Institute of Pharmaceutical Education and Research (NIPER) Guwahati on 27 August 2026 and was organised for the first time in the Northeast region. The meeting brought together experts and stakeholders from regulatory authorities, academia and scientific institutions to discuss strengthening quality and standardisation of phytopharmaceuticals in India.
Reference standards launched: Indian Pharmacopoeia Phytochemical Reference Standards (IPPRS) and Botanical Reference Standards (IPBRS)
IPC launched reference standards to support quality assurance and regulatory evaluation of plant-derived medicinal products. IPC introduced seven Indian Pharmacopoeia Phytochemical Reference Standards (IPPRS) and five Indian Pharmacopoeia Botanical Reference Standards (IPBRS). IPC stated the launch as the first-ever introduction of these critical reference standards by the Commission.
Phytochemical Reference Standards launched by IPC (IPPRS):
• Andrographolide
Related current affairs
- PCIM&H and IPC renew MoU for “One Herb, One Standard” to harmonise quality standards for traditional medicines
- Regulatory and quality measures for AYUSH products: WHO-CoPP facilitation, AYUSH Standard/Quality marks, ISO work, and standardization efforts in Kerala
- FICCI-DUA White Paper projects India’s medical device industry to reach $250 billion by 2047; stresses need for maintenance ecosystem
- WHO-SEARN recognises Indian Pharmacopoeia Commission (IPC) as Centre of Excellence in Pharmacovigilance and Technical Centre in Quality
- CDSCO approves India’s first dengue vaccine (Qdenga)
- Wegovy approved for fatty liver disease